Derivatives of N-` (1,5-diphenyl-1H-pyrazol-3-yl) sulphonamide with CB1 receptor affinity

Details for Australian Patent Application No. 2005209441 (hide)

Owner sanofi-aventis

Inventors Congy, Christian; Barth, Francis; Rinaldi-Carmona, Murielle; Martinez, Serge

Agent Davies Collison Cave

Pub. Number AU-B-2005209441

PCT Pub. Number WO2005/073197

Priority 0400257 12.01.04 FR

Filing date 7 January 2005

Wipo publication date 11 August 2005

Acceptance publication date 23 December 2010

International Classifications

C07D 231/12 (2006.01) Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

C07D 409/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 413/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

3 August 2006 PCT application entered the National Phase

  PCT publication WO2005/073197 Priority application(s): WO2005/073197

23 December 2010 Application Accepted

  Published as AU-B-2005209441

21 April 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005209442-Acylaminothiazole derivatives, preparation method thereof and use of same in therapeutics

2005209438-Suspended front steering system for multiple rotation cycles